Pain intensity. Pain, unspecified
Conditions
Interventions
Intervention 1: Intervention group 1: Methadone 0.2 mg/kg, made in Iran, Faran Shimi Company, intramuscularly for 24 hours, normal saline 0.1 mg/kg, made in Iran, Faran Shimi Company, intravenously fo
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Age 18 to 70 years Patients with ASA (American Society of Anesthesiologists) class1 and 2 Patients who are candidates for elective lumbar fusion surgery Consent to participate in the study
Exclusion criteria
Exclusion criteria: History of chronic renal failure before surgery Liver disease (cirrhosis or liver failure) Lung disease requiring home oxygen therapy History of methadone or morphine use History of allergy to methadone or morphine A history of recent use of any opiates or alcohol Patients who, for any reason, require prolonged intubation after surgery.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain intensity. Timepoint: Measurements at 1, 2, 6, 12, 24, and 48 hours after intervention injection. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sedation level on. Timepoint: Measurements at 1, 2, 6, 12, 24, and 48 hours after intervention injection. Method of measurement: Collins and Reed Attachment Style Questionnaire (RAAS). | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNafiseh Faghani Makrani
Mazandaran University of Medical Sciences
Outcome results
None listed